Halyard Health (NYSE: HYH) and Inogen (NASDAQ:INGN) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.
This table compares Halyard Health and Inogen’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Halyard Health and Inogen’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Halyard Health||$611.60 million||4.47||$79.30 million||$2.35||24.76|
|Inogen||$249.44 million||15.92||$21.00 million||$1.31||142.82|
Halyard Health has higher revenue and earnings than Inogen. Halyard Health is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
90.2% of Halyard Health shares are held by institutional investors. Comparatively, 97.9% of Inogen shares are held by institutional investors. 1.4% of Halyard Health shares are held by company insiders. Comparatively, 5.3% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
This is a breakdown of recent ratings and target prices for Halyard Health and Inogen, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Halyard Health currently has a consensus price target of $59.25, suggesting a potential upside of 1.82%. Inogen has a consensus price target of $188.75, suggesting a potential upside of 0.89%. Given Halyard Health’s higher probable upside, analysts plainly believe Halyard Health is more favorable than Inogen.
Volatility & Risk
Halyard Health has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.
Inogen beats Halyard Health on 8 of the 13 factors compared between the two stocks.
About Halyard Health
Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.